Patent US6727356B1 successfully refreshed from Google Patents.
← Back to Patent Explorer
US6727356B1 Expired / Lapsed US ⏱️ 0.0 years remaining

Fluorescent quenching detection reagents and methods

Assignee: DRUG ROYALTY TRUST 9
•
Filing: 1999-12-08
•
Granted: 2004-04-27
•
Expires: 2019-12-08
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Oligonucleotide-fluorophore-quencher conjugates wherein the fluorophore moiety has emission wavelengths in the range of about 300 to about 800 nm, and or where the quencher includes a substituted 4-(phenyldiazenyl)phenylamine structure provide improved signal to noise ratios and other advantageous characteristics in hybridization and related assays. The oligonucleotide-fluorophore-quencher conjugates can be synthesized by utilizing novel phosphoramidite reagents that incorporate the quencher moiety based on the substituted 4-(phenyldiazenyl)phenylamine structure, and or novel phosphoramidite reagents that incorporate a fluorophore moiety based on the substituted coumarin, substituted 7-hydroxy-3H-phenoxazin-3-one, or substituted 5,10-dihydro-10-[phenyl]pyrido[2,3-d;6,5-d']dipyrimidine-2,4,6,8-(1H,3H,7H,9H,10H)-tetrone structure. Oligonucleotide-fluorophore-quencher-minor groove binder conjugates including a pyrrolo[4,5-e]indolin-7-yl}carbonyl)pyrrolo[4,5-e]indolin-7-yl]carbonyl}pyrrolo[4,5-e]indoline-7-carboxylate (DPI3) moiety as the minor groove binder and the substituted 4-(phenyldiazenyl)phenylamine moiety as the quencher, were synthesized and have substantially improved hybridization and signal to noise ratio properties.

Inventors

  • 👤 Michael W. Reed
  • 👤 Eugeny Alexander Lukhtanov
  • 👤 Alexander A. Gall
  • 👤 Robert O. Dempcy

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 08:31
CPC Classifications
C; C07; C07D; C07D519/00; C07C; C07C245/00; C07C245/02; C07C245/06; C07C245/08; C07F; C07F9/00; C07F9/02; C07F9/06; C07F9/22; C07F9/24; C07F9/2404; C07F9/2408; C07F9/547; C07F9/553; C07F9/572; C07F9/655; C07F9/6552; C07F9/65522; C07F9/6561; C07H; C07H21/00; C09; C09B; C09B29/00; C09B29/06; C09B29/08; C09B29/0805; C09B29/0807; C09B29/0809; C09B29/0811; C09B29/0813; C12; C12Q; C12Q1/00; C12Q1/68; C12Q1/6813; C12Q1/6816; C12Q1/6818; C07B; C07B2200/00; C07B2200/11; C40; C40B; C40B40/00

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 172 words
An oligonucleotide conjugate having the formula FL-ODN-Q-MGB where ODN is an oligonucleotide or nucleic acid; FL is a fluorophore covalently attached to the ODN through a linker having the length of 0 to approximately 30 atoms, and Q is a quencher moiety covalently attached to the ODN through a linker having the length of 0 to approximately 30 atoms, the quencher moiety having the structure where R 0 , R 1 , R 2 , R 3 and R 4 are independently —H, halogen, —O(CH 2 ) n CH 3 , —(CH 2 ) n CH 3 where n=0 to 5, —NO 2 , —SO 3 , —N[(CH 2 ) n′ CH 3 ] 2 where n′=0 to 5 or —CN, and R 5 =—H, —(CH 2 ) n″ CH 3 or —(CH 2 ) n″ — where n″=0 to 5, and MGB is a minor groove binder moiety covalently attached to the ODN moiety or to the quencher moiety through a linker having the length of 0 to approximately 30 atoms.
Claim 2
Dependent Claim 172 words
An oligonucleotide conjugate having the formula FL-ODN-Q-MGB where ODN is an oligonucleotide or nucleic acid; FL is a fluorophore covalently attached to the ODN through a linker having the length of 0 to approximately 30 atoms, and Q is a quencher moiety covalently attached to the ODN through a linker having the length of 0 to approximately 30 atoms, the quencher moiety having the structure where R 0 , R 1 , R 2 , R 3 and R 4 are independently —H, halogen, —O(CH 2 ) n CH 3 , —(CH 2 ) n CH 3 where n=0 to 5, —NO 2 , —SO 3 , —N[(CH 2 ) n′ CH 3 ] 2 where n′=0 to 5 or —CN, and R 5 =—H, —(CH 2 ) n″ CH 3 or —(CH 2 ) n″ — where n″=0 to 5, and MGB is a minor groove binder moiety covalently attached to the ODN moiety or to the quencher moiety through a linker having the length of 0 to approximately 30 atoms.
Claim 3
Dependent Claim 50 words
An oligonucleotide conjugate in accordance with claim 1 where the MGB moiety is attached to the quencher moiety, and the covalently bonded MGB-Q moiety has the structure where t and v independently are 1 to 20, and the valence bond designated a attaches the MGB-Q moiety to the ODN moiety.
Claim 4
Dependent Claim 48 words
An oligonucleotide conjugate in accordance with claim 2 where R 0 is H, R 1 is NO 2 in the 4 position of the benzene nucleus, R 2 is H or Cl in the 2 position of the benzene nucleus, and R 3 and R 4 are hydrogen.
Claim 5
Dependent Claim 33 words
An oligonucleotide conjugate in accordance with claim 1 wherein said minor groove binder moiety (MGB) is attached to the quencher moiety through a linker having the length of 0 to approximately 30 atoms.
Claim 6
Dependent Claim 217 words
An oligonucleotide conjugate of the formula wherein R 0 , R 1 , R 2 , R 3 and R 4 are independently —H, halogen,—O(CH 2 ) n* CH 3 , —(CH 2 ) n* CH 3 where n*=0 to 5, —NO 2 , —SO 3 , —N[(CH 2 ) n′ CH 3 ] 2 where n′=0 to 5 or —CN; FL is a fluorophore moiety with emission wavelengths in the range of about 300 to about 800 nm; K is a linker from 1 to approximately 30 atoms in length; [A-B] n symbolizes an ODN, DNA, RNA or PNA or any combination thereof, where A is the sugar phosphate backbone where the sugar and the phosphate may independently be modified; B is a heterocyclic base, where B is independently selected from purine, pyrimidine, pyrazolo[3,4-d]pyrimidine, 7-substituted pyrazolo[3,4-d]pyrimidine-, 7-deazapurine, 7-substituted 7-deazapurine, and modified purine- and pyrimidine-bases, and where the DNA, RNA, PNA or ODN can include any combinations of these bases, and n, the number of nucleotide units in said DNA, RNA, PNA or ODN, is from about 5 to 100; W is a linker of a length of 1 to approximately 30 atoms, selected from the group consisting of C, O, N, S, and P; and m is an integer having the values of 1 to 20.
Claim 7
Dependent Claim 217 words
An oligonucleotide conjugate of the formula wherein R 0 , R 1 , R 2 , R 3 and R 4 are independently —H, halogen,—O(CH 2 ) n* CH 3 , —(CH 2 ) n* CH 3 where n*=0 to 5, —NO 2 , —SO 3 , —N[(CH 2 ) n′ CH 3 ] 2 where n′=0 to 5 or —CN; FL is a fluorophore moiety with emission wavelengths in the range of about 300 to about 800 nm; K is a linker from 1 to approximately 30 atoms in length; [A-B] n symbolizes an ODN, DNA, RNA or PNA or any combination thereof, where A is the sugar phosphate backbone where the sugar and the phosphate may independently be modified; B is a heterocyclic base, where B is independently selected from purine, pyrimidine, pyrazolo[3,4-d]pyrimidine, 7-substituted pyrazolo[3,4-d]pyrimidine-, 7-deazapurine, 7-substituted 7-deazapurine, and modified purine- and pyrimidine-bases, and where the DNA, RNA, PNA or ODN can include any combinations of these bases, and n, the number of nucleotide units in said DNA, RNA, PNA or ODN, is from about 5 to 100; W is a linker of a length of 1 to approximately 30 atoms, selected from the group consisting of C, O, N, S, and P; and m is an integer having the values of 1 to 20.
Claim 8
Dependent Claim 48 words
An oligonucleotide conjugate in accordance with claim 5 where R 0 is H, R 1 is NO 2 in the 4 position of the benzene nucleus, R 2 is H or Cl in the 2 position of the benzene nucleus, and R 3 and R 4 are hydrogen.
Claim 9
Dependent Claim 110 words
An oligonucleotide conjugate in accordance with claim 5 where said fluorophore moiety has the structure: where R 10 and R 11 independently are H, —OR 12 , —NH(R 13 ), —N(R 12 ) 2 , halogen,—O(CH 2 ) n CH 3 , —(CH 2 ) n CH 3 , —NO 2 , —SO 3 , —C(═O)NH 2 , —N[(CH 2 ) n CH 3 ] 2 or —CN where n=0 to 5 and R 12 and R 13 are each independently alkyl of 1 to 10 carbons or alkanoyl of 1 to 10 carbons; and the valence bond designated a symbolizes covalent attachment of the fluorophore to the linker K.
Claim 10
Dependent Claim 164 words
An oligonucleotide conjugate having the formula FL-ODN-MGB where ODN is an oligonucleotide or nucleic acid; MGB is minor groove binder moiety covalently attached to the ODN moiety or to the quencher moiety through a linker having the length of 0 to approximately 30 atoms; FL is a fluorophore covalently attached to the ODN through a linker having the length of 0 to approximately 30 atoms, said fluorophore moiety having the structure: R 10 and R 11 independently are H, —OR 12 , —NH(R 13 ), —N(R 12 ) 2 , halogen,—O(CH 2 ) n CH 3 , —(CH 2 ) n CH 3 , —NO 2 , —SO 3 , —C(═O)NH 2 , —N[(CH 2 ) n CH 3 ] 2 or —CN where n=0 to 5 and R 12 and R 13 are each independently alkyl of 1 to 10 carbons or alkanoyl of 1 to 10 carbons; and the valence bond designated a symbolizes covalent attachment of the fluorophore to the linker.
Claim 11
Dependent Claim 164 words
An oligonucleotide conjugate having the formula FL-ODN-MGB where ODN is an oligonucleotide or nucleic acid; MGB is minor groove binder moiety covalently attached to the ODN moiety or to the quencher moiety through a linker having the length of 0 to approximately 30 atoms; FL is a fluorophore covalently attached to the ODN through a linker having the length of 0 to approximately 30 atoms, said fluorophore moiety having the structure: R 10 and R 11 independently are H, —OR 12 , —NH(R 13 ), —N(R 12 ) 2 , halogen,—O(CH 2 ) n CH 3 , —(CH 2 ) n CH 3 , —NO 2 , —SO 3 , —C(═O)NH 2 , —N[(CH 2 ) n CH 3 ] 2 or —CN where n=0 to 5 and R 12 and R 13 are each independently alkyl of 1 to 10 carbons or alkanoyl of 1 to 10 carbons; and the valence bond designated a symbolizes covalent attachment of the fluorophore to the linker.
Claim 12
Dependent Claim 18 words
An oligonucleotide conjugate in accordance with claim 8 where R 10 is H and R 11 is H.

References Cited (Backward Citations)

US5304645A Cited
US5502177A Cited
US5801155A Cited
WO1997039008A1 Cited
US5952202A Cited
WO1999051621A2 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2007-04-27 2007-10-27 2008-04-27 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2011-04-27 2011-10-27 2012-04-27 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2015-04-27 2015-10-27 2016-04-27 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag